Oncogenesis

Papers
(The TQCC of Oncogenesis is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Retraction Note: Acetyl-CoA synthetase 3 promotes bladder cancer cell growth under metabolic stress113
Retraction Note: PI3K/Akt pathway and Nanog maintain cancer stem cells in sarcomas106
Non-genetic stratification reveals epigenetic heterogeneity and identifies vulnerabilities of glycolysis addiction in lung adenocarcinoma subtype83
AKT1 regulates UHRF1 protein stability and promotes the resistance to abiraterone in prostate cancer81
PELI1 and EGFR cooperate to promote breast cancer metastasis65
COX-2/PGE2 upregulation contributes to the chromosome 17p-deleted lymphoma52
Gemcitabine as chemotherapy of head and neck cancer in Fanconi anemia patients43
USP32 facilitates non-small cell lung cancer progression via deubiquitinating BAG3 and activating RAF-MEK-ERK signaling pathway39
DKK1 as a chemoresistant protein modulates oxaliplatin responses in colorectal cancer38
NRF2 signaling plays an essential role in cancer progression through the NRF2-GPX2-NOTCH3 axis in head and neck squamous cell carcinoma32
A cyclin D1 intrinsically disordered domain accesses modified histone motifs to govern gene transcription30
High expression of PSMC2 promotes gallbladder cancer through regulation of GNG4 and predicts poor prognosis30
Estradiol-mediated inhibition of DNMT1 decreases p53 expression to induce M2-macrophage polarization in lung cancer progression29
EHF suppresses cancer progression by inhibiting ETS1-mediated ZEB expression29
LUBAC promotes angiogenesis and lung tumorigenesis by ubiquitinating and antagonizing autophagic degradation of HIF1α28
Tumor-derived miR-130b-3p induces cancer-associated fibroblast activation by targeting SPIN90 in luminal A breast cancer27
Emerging role of G9a in cancer stemness and promises as a therapeutic target26
USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancer25
Activated platelet-derived exosomal LRG1 promotes multiple myeloma cell growth24
Engineered model of t(7;12)(q36;p13) AML recapitulates patient-specific features and gene expression profiles24
CCT8 recovers WTp53-suppressed cell cycle evolution and EMT to promote colorectal cancer progression23
miR-137–LAPTM4B regulates cytoskeleton organization and cancer metastasis via the RhoA-LIMK-Cofilin pathway in osteosarcoma23
TCF7L1 regulates cytokine response and neuroendocrine differentiation of prostate cancer23
CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancer23
EDDM3A drives gastric cancer progression by promoting HIF-1α-dependent aerobic glycolysis22
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment22
Clathrin adapters AP-1 and GGA2 support expression of epidermal growth factor receptor for cell growth21
Single-cell RNA sequencing reveals cell heterogeneity and transcriptome profile of breast cancer lymph node metastasis20
Androgen receptor variant 7 exacerbates hepatocarcinogenesis in a c-MYC-driven mouse HCC model20
AIFM2 promotes hepatocellular carcinoma metastasis by enhancing mitochondrial biogenesis through activation of SIRT1/PGC-1α signaling20
A novel uterine leiomyoma subtype exhibits NRF2 activation and mutations in genes associated with neddylation of the Cullin 3-RING E3 ligase20
The metastasis suppressor protein NM23-H1 modulates the PI3K-AKT axis through interaction with the p110α catalytic subunit20
Aberrant APOBEC3C expression induces characteristic genomic instability in pancreatic ductal adenocarcinoma18
Discovery of neddylation E2s inhibitors with therapeutic activity18
Vortioxetine hydrobromide inhibits the growth of gastric cancer cells in vivo and in vitro by targeting JAK2 and SRC18
Fibroblasts in metastatic lymph nodes confer cisplatin resistance to ESCC tumor cells via PI1617
Cytoglobin attenuates pancreatic cancer growth via scavenging reactive oxygen species17
LMW cyclin E and its novel catalytic partner CDK5 are therapeutic targets and prognostic biomarkers in salivary gland cancers17
Acidovorax temperans skews neutrophil maturation and polarizes Th17 cells to promote lung adenocarcinoma development17
Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcoma17
Mitotic MTH1 inhibitor TH1579 induces PD-L1 expression and inflammatory response through the cGAS-STING pathway17
Tumour cells express functional lymphatic endothelium-specific hyaluronan receptor in vitro and in vivo: Lymphatic mimicry promotes oral oncogenesis?17
Correction: FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway16
Correction to: FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway15
C20orf204, a hepatocellular carcinoma-specific protein interacts with nucleolin and promotes cell proliferation15
USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c15
Inhibition of Bruton’s tyrosine kinase as a therapeutic strategy for chemoresistant oral squamous cell carcinoma and potential suppression of cancer stemness15
Correction: Non-enzymatic heparanase enhances gastric tumor proliferation via TFEB-dependent autophagy15
RNF8 ubiquitinates RecQL4 and promotes its dissociation from DNA double strand breaks15
RIOK3 sustains colorectal cancer cell survival under glucose deprivation via an HSP90α-dependent pathway14
Inactivation of the CIC-DUX4 oncogene through P300/CBP inhibition, a therapeutic approach for CIC-DUX4 sarcoma14
LIN28B inhibition sensitizes cells to p53-restoring PPI therapy through unleashed translational suppression14
Heparanase modulates the prognosis and development of BRAF V600E-mutant colorectal cancer by regulating AKT/p27Kip1/Cyclin E2 pathway14
Co-activation of Sonic hedgehog and Wnt signaling in murine retinal precursor cells drives ocular lesions with features of intraocular medulloepithelioma14
Designing patient-oriented combination therapies for acute myeloid leukemia based on efficacy/toxicity integration and bipartite network modeling14
ACTL6A suppresses p21Cip1 tumor suppressor expression to maintain an aggressive mesothelioma cancer cell phenotype14
NOTCH1 signaling promotes protein stability of HER3 through the AKT pathway in squamous cell carcinoma of head and neck14
DUSP5P1 promotes gastric cancer metastasis and platinum drug resistance13
PKD phosphorylation and COP9/Signalosome modulate intracellular Spry2 protein stability13
Depletion of NK6 Homeobox 3 (NKX6.3) causes gastric carcinogenesis through copy number alterations by inducing impairment of DNA replication and repair regulation13
The prohibitin-binding compound fluorizoline inhibits mitophagy in cancer cells13
Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)12
Cell competition in primary and metastatic colorectal cancer12
Phosphorylation of IWS1 by AKT maintains liposarcoma tumor heterogeneity through preservation of cancer stem cell phenotypes and mesenchymal-epithelial plasticity12
Cell competition and cancer from Drosophila to mammals12
0.038907051086426